{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:26:15Z","timestamp":1777591575154,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009568","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000}}],"reference-count":28,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009568.pub2","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T01:38:21Z","timestamp":1607391501000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children"],"prefix":"10.1002","volume":"2020","author":[{"given":"Sabine","family":"B\u00e9lard","sequence":"additional","affiliation":[{"name":"Department of Paediatric Pulmonology, Immunology and Intensive Care Medicine; Charit\u00e9-Universit\u00e4tsmedizin Berlin; Berlin Germany"},{"name":"Berlin Institute of Health; Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf; Hamburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Kurth","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf; Hamburg Germany"},{"name":"Department of Infectious Diseases and Pulmonary Medicine, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health; Berlin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"issue":"9652","key":"10.1002\/14651858.CD009568.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(08)61492-0","article-title":"Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial","volume":"372","author":"Abdulla","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-10-369","article-title":"Similar efficacy and safety of artemether-lumefantrine (Coartem\u00ae) in African infants and children with uncomplicated falciparum malaria across different body weight ranges","volume":"10","author":"Bassat","year":"2011","journal-title":"Malaria Journal"},{"issue":"9","key":"10.1002\/14651858.CD009568.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"3994-9","DOI":"10.1128\/AAC.01115-10","article-title":"Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria","volume":"55","author":"Djimde","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e00596","DOI":"10.1128\/AAC.00596-17","article-title":"Efficacy and tolerability outcomes of a phase II, randomized, open-label, multicenter study of a new water-dispersible pediatric formulation of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria in African infants","volume":"62","author":"Gargano","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1475-2875-7-262","article-title":"A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya","volume":"7","author":"Juma","year":"2008","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12936-018-2370-x","article-title":"Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial","volume":"17","author":"Banek","year":"2018","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12936-018-2496-x","article-title":"A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali","volume":"17","author":"Dama","year":"2018","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4269\/ajtmh.2010.09-0265","article-title":"A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children","volume":"82","author":"Faye","year":"2010","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1475-2875-11-433","article-title":"Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate\/amodiaquine versus artemether\/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal","volume":"11","author":"Faye","year":"2012","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","article-title":"Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial","volume":"11","author":"Kayentao","year":"2012","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1475-2875-13-33","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study","volume":"13","author":"Ogutu","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12936-016-1281-y","article-title":"In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi","volume":"15","author":"Paczkowski","year":"2016","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12936-018-2340-3","article-title":"Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial","volume":"17","author":"Roth","year":"2018","journal-title":"Malaria Journal"},{"issue":"10128","key":"10.1002\/14651858.CD009568.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","volume":"391","author":"Sagara","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD009568.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","article-title":"Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial","volume":"16","author":"Sirima","year":"2016","journal-title":"Lancet Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD009568.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","article-title":"Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children","volume":"210","author":"Tahar","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009568.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-3156.2010.02701.x","article-title":"Artesunate\/mefloquine paediatric formulation vs. artemether\/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua koute, Cote d'Ivoire","volume":"16","author":"Toure","year":"2011","journal-title":"Tropical Medicine & International Health"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0018|cit18","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0019|cit19","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0020|cit20","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2) Available at: https:\/\/database.ich.org\/sites\/default\/files\/E9_Guideline.pdf 2016"},{"issue":"2","key":"10.1002\/14651858.CD009568.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-3099(09)70327-5","article-title":"Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis","volume":"10","author":"Kurth","year":"2010","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD009568.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.drudis.2018.01.038","article-title":"Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review","volume":"23","author":"Ranmal","year":"2018","journal-title":"Drug Discovery Today"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0023|cit23","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD009568.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jcph.1138","article-title":"Drug formulations: standards and novel strategies for drug administration in pediatrics","volume":"58","author":"Thabet","year":"2018","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0025|cit25","unstructured":"World Health Organization Methods for surveillance of antimalarial drug efficacy WHO Library 2009 2009"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0026|cit26","unstructured":"World Health Organization Guidelines for the treatment of malaria - 3rd edition www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/2015 2015"},{"key":"10.1002\/14651858.CD009568.pub2-BIB0027|cit27","unstructured":"World Health Organization World malaria report 2019 www.who.int\/publications-detail\/world-malaria-report-2019 2019"},{"issue":"1","key":"10.1002\/14651858.CD009568.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009568","article-title":"Paediatric formulations of artemisinin-combination therapies for treating uncomplicated malaria in children","author":"B\u00e9lard","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T09:47:01Z","timestamp":1659260821000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009568.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009568.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]}}}